Given the inverse correlation between BRCA1 and ErbB2 levels in tumours, it was expected that some component of the NRF-1 > GABP > BRCA1 pathway would be sensitive to ErbB2-overexpression. This evidence concerns the gene NRF1 and neoplasm.